Therapies Based on Nanoparticles for Eye Drug Delivery

Area of Science:

• Ophthalmology
• Nanotechnology
• Biomedical Engineering

Background:

• Posterior segment eye diseases like AMD, glaucoma, and diabetic retinopathy cause significant visual impairment globally.
• Efficient drug delivery to the posterior eye segment remains a major challenge in treating these conditions.

Purpose of the Study:

• To review the development and application of novel nanoparticle-based drug delivery systems for the posterior segment of the eye.
• To highlight the potential of emerging nanoparticles in improving drug retention and therapeutic outcomes.

Main Methods:

• Literature review of recent advancements in nanoparticle-based drug delivery for ocular applications.
• Analysis of different types of nanoparticles, with a focus on liposomes and emerging candidates.
• Evaluation of nanoparticle characteristics relevant to retinal drug delivery and retention.

Main Results:

• Nanoparticle-based systems, particularly liposomes, are increasingly utilized for eye drug delivery.
• Diverse novel nanoparticles are emerging as promising candidates with specialized characteristics for ocular drug delivery.
• These systems aim to enhance drug retention time within the posterior segment of the eye.

Conclusions:

• Nanoparticle drug delivery systems offer a viable solution to overcome the challenges of treating posterior segment eye diseases.
• Continued research into novel nanoparticles is essential for advancing ocular therapeutics and combating blindness.